Anna Borodovsky

10.6k total citations · 6 hit papers
43 papers, 6.7k citations indexed

About

Anna Borodovsky is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Anna Borodovsky has authored 43 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Oncology. Recurrent topics in Anna Borodovsky's work include Ubiquitin and proteasome pathways (11 papers), RNA Interference and Gene Delivery (9 papers) and Complement system in diseases (9 papers). Anna Borodovsky is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), RNA Interference and Gene Delivery (9 papers) and Complement system in diseases (9 papers). Anna Borodovsky collaborates with scholars based in United States, United Kingdom and Denmark. Anna Borodovsky's co-authors include Hidde L. Ploegh, Benedikt M. Kessler, Keith D. Wilkinson, Kevin Fitzgerald, William Querbes, Huib Ovaa, Matthias Nahrendorf, Daniel G. Anderson, Herman S. Overkleeft and Akin Akinc and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anna Borodovsky

43 papers receiving 6.5k citations

Hit Papers

Image-based analysis of lipid nanoparti... 1998 2026 2007 2016 2013 2012 2016 1998 2002 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Borodovsky United States 24 5.0k 1.0k 1.0k 689 621 43 6.7k
Dwayne G. Stupack United States 46 4.4k 0.9× 1.5k 1.4× 995 1.0× 1.2k 1.8× 749 1.2× 109 7.3k
Paule Opolon France 44 3.5k 0.7× 1.5k 1.5× 1.1k 1.1× 1.3k 1.8× 1.3k 2.1× 159 6.6k
Nadia Carlesso United States 32 2.7k 0.6× 973 1.0× 1.1k 1.1× 468 0.7× 317 0.5× 65 5.5k
Chand Khanna United States 49 3.4k 0.7× 2.3k 2.3× 1.1k 1.1× 1.4k 2.0× 1.3k 2.0× 126 7.8k
Alan M. Gewirtz United States 46 4.6k 0.9× 1.2k 1.2× 1.2k 1.1× 612 0.9× 648 1.0× 158 7.8k
Akira Komoriya United States 30 2.9k 0.6× 867 0.8× 980 1.0× 774 1.1× 378 0.6× 55 5.6k
Richard C. Bates United States 32 2.2k 0.4× 1.6k 1.5× 568 0.6× 566 0.8× 397 0.6× 51 4.3k
Kevin L. Moore United States 37 3.3k 0.7× 843 0.8× 2.9k 2.9× 1.1k 1.5× 348 0.6× 59 8.1k
Radu V. Stan United States 36 4.1k 0.8× 406 0.4× 727 0.7× 408 0.6× 556 0.9× 58 6.3k
Mirco Ponzoni Italy 44 3.4k 0.7× 1.2k 1.2× 1.0k 1.0× 1.1k 1.6× 324 0.5× 174 5.9k

Countries citing papers authored by Anna Borodovsky

Since Specialization
Citations

This map shows the geographic impact of Anna Borodovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Borodovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Borodovsky more than expected).

Fields of papers citing papers by Anna Borodovsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Borodovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Borodovsky. The network helps show where Anna Borodovsky may publish in the future.

Co-authorship network of co-authors of Anna Borodovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Borodovsky. A scholar is included among the top collaborators of Anna Borodovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Borodovsky. Anna Borodovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deaton, Aimée M., Lynne Krohn, Paul Nioi, et al.. (2025). Rare predicted loss-of-function and damaging missense variants in CFHR5 associate with protection from age-related macular degeneration. The American Journal of Human Genetics. 112(5). 1062–1080. 1 indexed citations
2.
Barratt, Jonathan, Adrian Liew, See Cheng Yeo, et al.. (2024). Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical Journal of the American Society of Nephrology. 19(4). 452–462. 28 indexed citations
3.
Badri, Prajakta, Xuemin Jiang, Anna Borodovsky, et al.. (2020). Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria. Clinical Pharmacokinetics. 60(3). 365–378. 58 indexed citations
4.
Liu, Jingxuan, Brian C. Cooley, Akin Akinc, James Butler, & Anna Borodovsky. (2020). Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function. Thrombosis Research. 196. 200–205. 17 indexed citations
5.
Kusner, Linda L., Kristina Yucius, Manjistha Sengupta, et al.. (2019). Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis. Molecular Therapy — Methods & Clinical Development. 13. 484–492. 42 indexed citations
6.
Banda, Nirmal K., Robert I. Scheinman, Rasmus Pihl, et al.. (2018). Targeting of Liver Mannan-Binding Lectin–Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis. ImmunoHorizons. 2(8). 274–295. 15 indexed citations
7.
Liu, Jingxuan, June Qin, Anna Borodovsky, et al.. (2018). An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema. RNA. 25(2). 255–263. 32 indexed citations
8.
Fitzgerald, Kevin, Anna Borodovsky, Brian R. Bettencourt, et al.. (2016). A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. New England Journal of Medicine. 376(1). 41–51. 586 indexed citations breakdown →
9.
Rajeev, Kallanthottathil G., Jayaprakash K. Nair, Muthusamy Jayaraman, et al.. (2015). Hepatocyte‐Specific Delivery of siRNAs Conjugated to Novel Non‐nucleosidic Trivalent N‐Acetylgalactosamine Elicits Robust Gene Silencing in Vivo. ChemBioChem. 16(6). 903–908. 148 indexed citations
10.
Courties, Gabriel, Timo Heidt, Matthew Sebas, et al.. (2013). In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing. Journal of the American College of Cardiology. 63(15). 1556–1566. 227 indexed citations
11.
Gilleron, Jérôme, William Querbes, Anja Zeigerer, et al.. (2013). Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape. Nature Biotechnology. 31(7). 638–646. 1232 indexed citations breakdown →
12.
Pappu, Bhanu P., Anna Borodovsky, Timothy S. Zheng, et al.. (2008). TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. The Journal of Experimental Medicine. 205(5). 1049–1062. 177 indexed citations
13.
Dohi, Taeko, Anna Borodovsky, Ping Wu, et al.. (2008). TWEAK/Fn14 Pathway: A Nonredundant Role in Intestinal Damage in Mice Through a TWEAK/Intestinal Epithelial Cell Axis. Gastroenterology. 136(3). 912–923.e8. 61 indexed citations
14.
Hemelaar, Joris, Anna Borodovsky, Benedikt M. Kessler, et al.. (2003). Specific and Covalent Targeting of Conjugating and Deconjugating Enzymes of Ubiquitin-Like Proteins. Molecular and Cellular Biology. 24(1). 84–95. 176 indexed citations
15.
Kessler, Benedikt M., Jelena Petrovic, Anna Borodovsky, et al.. (2003). Pathways Accessory to Proteasomal Proteolysis Are Less Efficient in Major Histocompatibility Complex Class I Antigen Production. Journal of Biological Chemistry. 278(12). 10013–10021. 24 indexed citations
16.
Vugmeyster, Yulia, Anna Borodovsky, Madelon M. Maurice, et al.. (2002). The ubiquitin–proteasome pathway in thymocyte apoptosis: caspase-dependent processing of the deubiquitinating enzyme USP7 (HAUSP). Molecular Immunology. 39(7-8). 431–441. 29 indexed citations
17.
Borodovsky, Anna, Huib Ovaa, Nagamalleswari Kolli, et al.. (2002). Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family. Chemistry & Biology. 9(10). 1149–1159. 474 indexed citations
18.
Leggett, David, John Hanna, Anna Borodovsky, et al.. (2002). Multiple Associated Proteins Regulate Proteasome Structure and Function. Molecular Cell. 10(3). 495–507. 506 indexed citations breakdown →
19.
Borodovsky, Anna, Benedikt M. Kessler, Rocco Casagrande, et al.. (2001). A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. The EMBO Journal. 20(18). 5187–5196. 410 indexed citations
20.
Jensen, David E., Sandra T. Marquis, Heather Perry Gardner, et al.. (1998). BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 16(9). 1097–1112. 569 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026